JCS 2022 guideline on management and re-interventional therapy in patients with congenital heart disease long-term after initial repair

H Ohuchi, M Kawata, H Uemura, T Akagi, A Yao… - Circulation …, 2022 - jstage.jst.go.jp
The number of patients with congenital heart disease (CHD), particularly those with complex
malformations, is rapidly increasing thanks to recent improvements in surgical outcomes. It …

Depressive symptoms and quality of life in patients with heart failure and an implantable cardioverter-defibrillator

C Zormpas, KG Kahl, S Hohmann, H Oswald… - Frontiers in …, 2022 - frontiersin.org
Background Heart failure (HF) is associated with development of depressive symptoms and
reduced quality of life (QoL). Patients with HF and an implantable cardioverter-defibrillator …

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease

C Zormpas, AS Silber‐Peest, J Eiringhaus… - ESC Heart …, 2021 - Wiley Online Library
Aims Patients with adult congenital heart disease (ACHD) carry an increased risk for sudden
cardiac death. Implantable cardioverter‐defibrillator (ICD) therapy may be challenging in …

Patient after correction Taussig‐Bing anomaly with severe neo‐aortic regurgitation after sudden cardiac arrest

A Bielecka‐Dabrowa, A Bikiewicz, M Rybak… - Clinical Case …, 2021 - Wiley Online Library
Abstract The Taussig‐Bing anomaly is a rare cyanotic congenital heart defect treated
surgically in the early infancy. The preferred repair procedure is an arterial switch operation …

Effect of malnutrition on outcomes of patients hospitalized for implantable cardioverter-defibrillator implantation

IR Asemota, H Shaka, E Akuna, E Edigin… - Available at SSRN …, 2022 - papers.ssrn.com
Background: Implantable cardioverter-defibrillator (ICD) implantation is an invasive
procedure that is associated with potential morbidity and mortality. Frail hospitalized older …